MDx Impact Grants (2026-2027)
Nature Awards
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Sep 2, 2026
- Closes
- Nov 20, 2026 (in 36 days)
- Last verified
- Oct 9, 2026
Similar opportunities open now
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)OpenNational Institutes of HealthCloses Nov 19, 2026 (in 35 days)
- Translational Diagnostics Advanced Training GrantOpenCAP Foundation Grants and Awards Application SiteCloses Nov 2, 2026 (in 18 days)Up to $5K
- Sparking Interest in Pathology AwardOpenCAP Foundation Grants and Awards Application SiteCloses Dec 1, 2026 (in 47 days)Up to $500
- Simons Foundation: New Ideas — Request for ApplicationsOpenSimons FoundationNo deadline listedUp to $300K
- John H. Rippey, MD Grant for Laboratory Quality AssuranceOpenCAP Foundation Grants and Awards Application SiteCloses Nov 16, 2026 (in 32 days)Up to $10K
Amount
Amount not listed here. Check the official program.
Who can apply
Each research group is permitted to submit only one application focused on the designated project. We welcome applications from eligible research groups from around the world…
About this opportunity
The MDx Impact Grants aim to unlock the potential of PCR to democratise access to accurate diagnostic tests that improve patient outcomes. We invite research groups to work with us and our partner Seegene to develop tests that address unmet clinical needs. The programme provides researchers with access to Seegene’s syndromic PCR technology and development grants of up to 600,000 USD to perform clinical studies. Each research group is permitted to submit only one application focused on the designated project. We welcome applications from eligible research groups from around the world. 2026 Scope: Neurodegenerative Disease Diagnostics with a Focus on Alzheimer's Disease This year, the MDx Impact Grants focus on Alzheimer's disease (AD), inviting researchers to propose how Seegene's high-mult...